Home › NDC Lookup › Ingredients › Bacitracin › 00713-0280-31
🧴image loading
(from DailyMed)

Bacitracin 500 [USP'U]/g Ointment, 28.4 g — NDC 0713-0280-31 (Billing 00713-0280-31)

by Cosette Pharmaceuticals, Inc. · 28.4 g in 1 TUBE

This is a package of 28.4 g of Bacitracin 500 [USP'U]/g Ointment from Cosette Pharmaceuticals, Inc., marketed since Jan 1995 and currently FDA-listed; retail pharmacies pay about $0.0735 per g (NADAC). It is this product's only package size.

NDC 00713-0280-31
🏷️ FDA NDC (as labeled) 0713-0280-31 billing pads the labeler segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 0713-0280-31 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
0713 labeler · 0280 product · 31 package
Package marketed since
Jan 10, 1995
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
28 g per package
Barcode (UPC-A, from the NDC)
3 0713028031 0
Medicaid fills, this package
46,052 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0713-0280-31
Product NDC 0713-0280
11-digit billing NDC 00713028031
NCPDP billing unit GM — per gram (weight)
RxCUI 1648110
UNII 58H6RWO52I
Application # M004
SPL Set ID 630e0841-baf2-e9fa-b309-ad1a5f95da3b
Physiologic effect Decreased Cell Wall Synthesis & Repair
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 1995-01-10
Route TOPICAL
Dosage form OINTMENT
Substance BACITRACIN

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 90100010004210
GPI class Bacitracin
GCN Seq No 007731
GCN 31812
HICL code 004047
Ingredient (HICL) Bacitracin
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q5
Therapeutic class — intermediate (HIC2) Agents Acting Principally On The Skin
HIC3 code Q5W
Therapeutic class — specific (HIC3) Topical Antibiotics
AHFS code 84:04.04.00
AHFS class Antibacterials (84:04)
FDB label name BACITRACIN 500 UNIT/GM OINTMNT
FDB brand name Bacitracin
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 007731
  • GCN: 31812
  • GPI-14 (Medi-Span): 90100010004210
  • HICL (First Databank): 004047
  • AHFS class code: 84:04.04.00
  • RxCUI (RxNorm): 1648110
Why two NDCs? The FDA registers this code as 0713-0280-31 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00713-0280-31. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Other antibiotics for topical use class.

Drug family (ATC) Other antibiotics for topical use, Other antibacterials, Antibiotics
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name BACITRACIN 500 UNIT/GM OINTMNT Ingredient Bacitracin
📖 What it is MedlinePlus · NLM

Bacitracin is used to help prevent minor skin injuries such as cuts, scrapes, and burns from becoming infected. Bacitracin is in a class of medications called antibiotics. Bacitracin works by stopping the growth of bacteria.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It is first aid to help prevent infection in minor cuts, scrapes, and burns. One cream product also has directions for athlete's foot, ringworm and jock itch.
  • Clean the area, then put on a small amount, about the size of your fingertip. Do this 1 to 3 times a day, and you can cover it with a sterile bandage. One cream product is used as...
  • Not longer than 1 week unless a doctor tells you to. If the problem is not getting better or gets worse, stop and check with a doctor.
  • Stop if you get a rash or any allergic reaction, and talk to a doctor. Don't use it if you are allergic to any ingredient.
📖 Read our full Bacitracin Topical guide →
7
Nutrient depletion considerations

Bacitracin may be associated with lower levels of 7 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Bacitracin nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly $0.074 $2.09 / 28.4 g
Medicaid paysCMS SDUD · 12 mo $0.4720 $13.40 / 28.4 g
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per g) — tap or hover for the price & month
Jan 2022 Aug 2022 Jan 2026 Sep 2026 $0.077 $0.066
▲ Up 3% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00713-0280-31 You're viewing this Main listing 28.4 g in 1 TUBE 1995-01-10 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Bacitracin 500 U/g 00536-1256-28 RUGBY 30 g $0.055 — Availability likely save 25%
Bacitracin 500 [USP'U]/gthis 00713-0280-31 Cosette 28.4 g $0.073 — Availability likely —
Bacitracin 500 [iU]/g 68001-0477-46 BluePoint 1 tube $0.094 — Availability likely +27%
Bacitracin 500 [USP'U]/g 45802-0060-01 Padagis 1 tube $0.117 — Availability likely +60%
Major Bacitracin 500 [USP'U]/g 00904-7402-67 Major 144 packets $0.121 — FDA listed +64%
signature care first aid antibiotic 500 [USP'U]/g 21130-0757-64 Safeway 1 tube — — FDA listed —
Bacitracin 500 [USP'U]/g 30142-0536-64 Kroger 1 tube — — FDA listed —
Antibiotic 500 [USP'U]/g 36800-0536-64 Topco 1 tube — — FDA listed —
bacitracin 500 [USP'U]/g 37808-0536-64 H 1 tube — — FDA listed —
MediChoice Bacitracin 500 [iU]/g 39892-0810-01 O&M 144 packets — — FDA listed —
Bacitracin 500 [USP'U]/g 41226-0880-02 Kroger 1 tube — — FDA listed —
Bacitracin 500 [USP'U]/g 41250-0844-64 Meijer 1 tube — — FDA listed —
first aid antibiotic 500 [USP'U]/g 42507-0536-64 HyVee 1 tube — — FDA listed —
Bacitracin 500 [USP'U]/g 50090-0815-00 A-S 1 tube — — FDA listed —
Bacitracin 500 [USP'U]/g 50090-0845-00 A-S 144 packets — — FDA listed —
Rexall Antibiotic 500 [USP'U]/g 55910-0536-64 Dolgencorp, 1 tube — — FDA listed —
Publix Bacitracin Zinc 500 [USP'U]/g 56062-0815-28 PUBLIX 1 tube — — FDA listed —
Bacitracin 500 [USP'U]/g 59779-0536-64 CVS 1 tube — — FDA listed —
Bacitracin 500 [iU]/g 63187-0299-01 Proficient 28.35 g — — FDA listed —
Bacitracin 500 [USP'U]/1000mg 67777-0116-10 Dynarex 144 packets — — FDA listed —
Bacitracin 500 [USP'U]/g 68071-5253-03 NuCare 28.4 g — — FDA listed —
Bacitracin 500 [USP'U]/g 68788-8643-02 Preferred 28.4 g — — FDA listed —
Bacitracin 500 [USP'U]/g 68788-9794-02 Preferred 28 g — — FDA listed —
TheraCare Bacitracin Zinc 500 [USP'U]/g 71101-0019-01 Veridian 1 tube — — FDA listed —
Bacitracin 500 [USP'U]/g 71205-0057-01 Proficient 28.4 g — — FDA listed —
Vitastem Ultra First Aid Antibiotic 500 U/g 71262-0013-15 Viaderma 1 bottle — — FDA listed —
Viaderma Care First Aid 500 U/g 71262-0015-15 ViaDerma 1 bottle — — FDA listed —
Bacitracin 500 [USP'U]/g 71335-2731-01 Bryant 144 packets — — FDA listed —
Bacitracin 500 [USP'U]/g 72162-2280-02 Bryant 144 packets — — FDA listed —
astonea First Aid 500 [USP'U]/g 77338-0303-52 ASTONEA 9 g — — FDA listed —
Bacitracin 500 [USP'U]/g 84387-0002-01 ALLIED 28.4 g — — FDA listed —
Bacitracin 500 [iU]/g 87236-0000-01 AlderMed 1 tube — — FDA listed —
Medi-First Bacitracin Zinc 500 [USP'U]/g 47682-0863-66 Unifirst 1 tube — — FDA listed —
Zapotol Bacitracin 500 [USP'U]/g 59428-0135-14 Zapatol 1 tube — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
1995
On the market since
Jan 1995
📍
2026
Currently FDA-listed
31 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerCosette Pharmaceuticals, Inc.
FDA applicationM004 (OTC MONOGRAPH DRUG)
Labeler code00713
First marketedJan 1995
Product typeHuman Otc Drug
Portfolio99 products on file

More NDCs from Cosette Pharmaceuticals, Inc. labeler code 00713

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 13 words ▾

USES first aid to help prevent infection in minor cuts, scrapes and burns

⏱️ Dosage and Administration 43 words ▾

DIRECTIONS • clean the affected area • apply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily • may be covered with a sterile bandage

⚠️ Warnings 78 words ▾

WARNINGS For external use only Do not use • if you are allergic to any of the ingredients • in the eyes • over large areas of the body • longer than 1 week unless directed by a doctor Ask a doctor before use in case of deep or puncture wounds, animal bites, or serious burns Stop use and ask a doctor if • the condition persists or gets worse • a rash or other allergic reaction develops

🧪 Active Ingredient 5 words ▾

ACTIVE INGREDIENT Bacitracin 500 units

🧪 Inactive Ingredients 7 words ▾

INACTIVE INGREDIENT light mineral oil, white petrolatum

🎯 Purpose 4 words ▾

PURPOSE First aid antibiotic

📄 Keep Out of Reach of Children 19 words ▾

KEEP OUT OF REACH OF CHILDREN If swallowed, get medical help or contact a Poison Control Center right away.

📄 Package Label / Principal Display Panel 19 words ▾

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Cosette Pharmaceuticals, Inc. Bacitracin Ointment FIRST AID ANTIBIOTIC Net Wt. 1 oz (28.4 g) unit-carton

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
46.1K
Units reimbursed last 4 qtrs
1.4M
Gross reimbursed last 4 qtrs
$656.3K
Avg / prescription
$14.25
Avg / unit
$0.4720
Latest quarter Q1 2026
7.2KRx
Medicaid pays / g
$0.4720
gross reimbursed
vs
NADAC / g
$0.0735
acquisition cost
=
Spread
+$0.3985
+542% vs cost
What Medicaid paid per g (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
67% FFS 33% MCO
Fee-for-service · 31,001 Rx Managed care · 15,051 Rx
State Medicaid map
Alaska: no data reported AK Maine: 5,652 units · 405 per 100k residents ME Washington: 45,128 units · 578 per 100k residents WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 19,586 units · 341 per 100k residents MN Wisconsin: 17,544 units · 297 per 100k residents WI Michigan: 66,956 units · 667 per 100k residents MI New York: 8,044 units · 41.1 per 100k residents NY Vermont: 2,073 units · 320 per 100k residents VT New Hampshire: no data reported NH Oregon: 6,899 units · 163 per 100k residents OR Nevada: 11,392 units · 357 per 100k residents NV Wyoming: no data reported WY South Dakota: 187 units · 20.3 per 100k residents SD Iowa: 5,151 units · 161 per 100k residents IA Illinois: 23,366 units · 186 per 100k residents IL Indiana: 51,247 units · 747 per 100k residents IN Ohio: 49,566 units · 421 per 100k residents OH Pennsylvania: 33,496 units · 258 per 100k residents PA New Jersey: 13,888 units · 149 per 100k residents NJ Massachusetts: 35,301 units · 504 per 100k residents MA California: 769,814 units · 1,976 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 7,924 units · 401 per 100k residents NE Missouri: no data reported MO Kentucky: 49,295 units · 1,089 per 100k residents KY West Virginia: 8,948 units · 506 per 100k residents WV Virginia: 14,552 units · 167 per 100k residents VA Maryland: 10,593 units · 171 per 100k residents MD Connecticut: no data reported CT Rhode Island: 7,838 units · 716 per 100k residents RI Arizona: 24,310 units · 327 per 100k residents AZ New Mexico: 8,292 units · 392 per 100k residents NM Kansas: 653 units · 22.2 per 100k residents KS Arkansas: 2,316 units · 75.5 per 100k residents AR Tennessee: 6,440 units · 90.4 per 100k residents TN North Carolina: no data reported NC South Carolina: 2,513 units · 46.8 per 100k residents SC Delaware: 4,515 units · 438 per 100k residents DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: 4,843 units · 165 per 100k residents MS Alabama: no data reported AL Georgia: 12,127 units · 110 per 100k residents GA D.C.: 2,877 units · 424 per 100k residents DC Hawaii: 10,763 units · 750 per 100k residents HI Texas: 46,372 units · 152 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
20.31,976
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 California 1,976 /100k
2 Kentucky 1,089 /100k
3 Hawaii 750 /100k
4 Indiana 747 /100k
5 Rhode Island 716 /100k
6 Michigan 667 /100k
7 Washington 578 /100k
8 West Virginia 506 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Bacitracin — the program that covers self-administered drugs. 1 manufacturer.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Bacitracin. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$3.9K
Claims incl. refills
44
Beneficiaries
42
Spend / beneficiary
$92.36
Spend / claim
$88.16
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
← 00713-0268-31 · Cosette 00713-0318-53 · Cosette →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.